Clinical trial
A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust…
NCT00250263 · Bayside Health, Other · Completed
Key facts
| NCT number | NCT00250263 |
|---|---|
| Title | A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy |
| Official title | A Trial of Immunological Outcomes of Sublingual Immunotherapy for House Dust Mite (D. Pteronyssinus) Allergy |
| Lead sponsor | Bayside Health, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis, Asthma |
| Intervention type | Drug |
| Interventions | (agent for immunotherapy) Staloral, Placebo |
| Enrollment | 30 |
| Start date | Nov 1, 2005 |
| Primary completion | Dec 1, 2008 |
| Completion | Dec 1, 2008 |
| First posted | Nov 8, 2005 |
| Last update posted | Feb 13, 2013 |
| Countries | Australia |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: